Denali Therapeutics Issues Public Comment on FDA Notice Assessing Electronic Health Records, Medical Claims Data to Support Regulatory Decision-Making for Drug, Biological Products
2021-11-30
zz-Public Comments2021-11-30
Targeted News Service
WASHINGTON, Nov. 30 -- Denali Therapeutics Inc., South San Francisco, California, has issued a public comment on the Food and Drug Administration notice entitled "Real-World Data: Assessing Electronic . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, Nov. 30 -- Denali Therapeutics Inc., South San Francisco, California, has issued a public comment on the Food and Drug Administration notice entitled "Real-World Data: Assessing Electronic . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2021